Payment overview · 2025
General Payments
$337.34
18 reported records · 11 companies
Healthcare provider profile · identity verified
John E. Lloyd, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · LANCASTER, OH · NPI 1740252923
Verified facts
What the public records show
CMS Open Payments records show John E. Lloyd, M.D. received $337.34 in general payments during 2025 across 18 reported records.
PFIZER INC. accounted for 28.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 13 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Arexvy, Eliquis, Ozempic, Rexulti, Shingrix.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 87 claims for Trelegy Ellipta by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Rexulti by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 97 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Rybelsus by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1097 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $95.61 | 28.3% | 5 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $60.28 | 17.9% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $32.09 | 9.5% | 2 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $28.93 | 8.6% | 1 | 2025 |
| Insmed, Inc. | Unresolved — no canonical attribution shown | $28.00 | 8.3% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $17.07 | 5.1% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $17.03 | 5.0% | 1 | 2025 |
| Amphastar Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $16.97 | 5.0% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $16.79 | 5.0% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $15.07 | 4.5% | 1 | 2025 |
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $9.50 | 2.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $337.34 | 18 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $95.61 | 5 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $72.32 | 4 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $60.28 | 3 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $32.09 | 2 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $28.93 | 1 | 2025 |
Source payment records
|
|||||
| Arikayce Normalized: arikayce |
Drug | Insmed, Inc. | $28.00 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $23.29 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $17.07 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $17.07 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $17.03 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $16.79 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $15.07 | 1 | 2025 |
Source payment records
|
|||||
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $9.50 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AREXVY arexvy |
2025 | Arexvy | 2024 | 14 | exact normalized | Medicare Part D |
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 1097 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 97 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 13 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| SHINGRIX shingrix |
2025 | Shingrix | 2024 | 49 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
14 | 14 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
49 | 43 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
87 | 17 |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
97 | 19 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
23 | 23 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1097 | 167 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
13 | 13 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1940 | 352 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1441 | 230 |
| Eliquis | Apixaban | 1097 | 167 |
| Furosemide | Furosemide | 991 | 196 |
| Gabapentin | Gabapentin | 936 | 172 |
| Donepezil Hcl | Donepezil Hcl | 848 | 117 |
| Metformin Hcl | Metformin Hcl | 847 | 145 |
| Memantine Hcl | Memantine Hcl | 820 | 112 |
| Lisinopril | Lisinopril | 766 | 149 |
| Mirtazapine | Mirtazapine | 747 | 127 |
| Buspirone Hcl | Buspirone Hcl | 732 | 122 |
| Sertraline Hcl | Sertraline Hcl | 731 | 117 |
| Tamsulosin Hcl | Tamsulosin Hcl | 725 | 127 |
| Pantoprazole Sodium | Pantoprazole Sodium | 697 | 155 |
| Metoprolol Succinate | Metoprolol Succinate | 586 | 114 |
| Amlodipine Besylate | Amlodipine Besylate | 581 | 121 |
| Potassium Chloride | Potassium Chloride | 527 | 125 |
| Omeprazole | Omeprazole | 517 | 122 |
| Pioglitazone Hcl | Pioglitazone Hcl | 490 | 94 |
| Metoprolol Tartrate | Metoprolol Tartrate | 483 | 103 |
| Trazodone Hcl | Trazodone Hcl | 440 | 105 |
| Escitalopram Oxalate | Escitalopram Oxalate | 437 | 79 |
| Clopidogrel | Clopidogrel Bisulfate | 425 | 84 |
| Carvedilol | Carvedilol | 420 | 79 |
| Bupropion Xl | Bupropion Hcl | 404 | 69 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 393 | 49 |
| Losartan Potassium | Losartan Potassium | 388 | 97 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 388 | 111 |
| Jardiance | Empagliflozin | 354 | 49 |
| Spironolactone | Spironolactone | 344 | 55 |
| Januvia | Sitagliptin Phosphate | 330 | 51 |
| Finasteride | Finasteride | 328 | 55 |
| Levetiracetam | Levetiracetam | 323 | 33 |
| Prednisone | Prednisone | 307 | 109 |
| Simvastatin | Simvastatin | 305 | 66 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 293 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 272 | 48 |
| Quetiapine Fumarate | Quetiapine Fumarate | 263 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 262 | 48 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 246 | 28 |
| Lamotrigine | Lamotrigine | 243 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 240 | 48 |
| Famotidine | Famotidine | 239 | 51 |
| Ondansetron Hcl | Ondansetron Hcl | 210 | 102 |
| Aripiprazole | Aripiprazole | 209 | 28 |
| Bumetanide | Bumetanide | 209 | 35 |
| Allopurinol | Allopurinol | 204 | 42 |
| Nystatin | Nystatin | 201 | 57 |
| Galantamine Er | Galantamine Hbr | 199 | 36 |
| Divalproex Sodium | Divalproex Sodium | 196 | 26 |
| Montelukast Sodium | Montelukast Sodium | 185 | 36 |
| Xarelto | Rivaroxaban | 185 | 39 |
| Oxycodone Hcl | Oxycodone Hcl | 182 | 40 |
| Primidone | Primidone | 179 | 25 |
| Alprazolam | Alprazolam | 178 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 177 | 86 |
| Baclofen | Baclofen | 174 | 23 |
| Celecoxib | Celecoxib | 172 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 166 | 41 |
| Latanoprost | Latanoprost | 166 | 31 |
| Ropinirole Hcl | Ropinirole Hcl | 162 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 159 | 48 |
| Trulicity | Dulaglutide | 159 | 12 |
| Alendronate Sodium | Alendronate Sodium | 156 | 24 |
| Tradjenta | Linagliptin | 148 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 146 | 58 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 146 | 27 |
| Lorazepam | Lorazepam | 145 | 36 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 144 | 31 |
| Tresiba Flextouch U-100 | Insulin Degludec | 142 | 23 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 139 | 41 |
| Risperidone | Risperidone | 132 | 21 |
| Tramadol Hcl | Tramadol Hcl | 129 | 37 |
| Nifedipine Er | Nifedipine | 128 | 29 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 124 | 28 |
| Digoxin | Digoxin | 121 | 15 |
| Mounjaro | Tirzepatide | 112 | 11 |
| Albuterol Sulfate | Albuterol Sulfate | 111 | 36 |
| Chlorthalidone | Chlorthalidone | 111 | 20 |
| Olanzapine | Olanzapine | 110 | 18 |
| Clonazepam | Clonazepam | 107 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 106 | 28 |
| Sucralfate | Sucralfate | 104 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 102 | 34 |
| Buprenorphine | Buprenorphine | 102 | 22 |
| Ranolazine Er | Ranolazine | 101 | 12 |
| Novolog Flexpen | Insulin Aspart | 100 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 97 | 16 |
| Ozempic | Semaglutide | 97 | 19 |
| Lactulose | Lactulose | 96 | 19 |
| Gemtesa | Vibegron | 95 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 95 | 18 |
| Cilostazol | Cilostazol | 94 | 17 |
| Prazosin Hcl | Prazosin Hcl | 90 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 90 | 27 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 87 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 87 | 42 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 87 | 17 |
| Cefdinir | Cefdinir | 86 | 58 |
| Acetic Acid | Acetic Acid | 84 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 84 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 84 | 54 |
| Diclofenac Sodium | Diclofenac Sodium | 83 | 27 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 82 | 24 |
| Midodrine Hcl | Midodrine Hcl | 82 | 16 |
| Pregabalin | Pregabalin | 81 | 16 |
| Warfarin Sodium | Warfarin Sodium | 81 | 14 |
| Topiramate | Topiramate | 79 | 14 |
| Torsemide | Torsemide | 79 | 22 |
| Entresto | Sacubitril/Valsartan | 78 | suppressed |
| Meloxicam | Meloxicam | 77 | 23 |
| Doxepin Hcl | Doxepin Hcl | 76 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 74 | 52 |
| Cephalexin | Cephalexin | 74 | 43 |
| Farxiga | Dapagliflozin Propanediol | 74 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 72 | 41 |
| Sodium Chloride | 0.9 % Sodium Chloride | 72 | 30 |
| Humalog Kwikpen U-100 | Insulin Lispro | 69 | 20 |
| Ezetimibe | Ezetimibe | 68 | suppressed |
| Fluconazole | Fluconazole | 68 | 38 |
| Budesonide | Budesonide | 67 | suppressed |
| Myrbetriq | Mirabegron | 67 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 67 | 19 |
| Clozapine | Clozapine | 65 | suppressed |
| Ondansetron Odt | Ondansetron | 63 | 28 |
| Dicyclomine Hcl | Dicyclomine Hcl | 62 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 61 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 61 | 11 |
| Meclizine Hcl | Meclizine Hcl | 61 | 21 |
| Metformin Hcl Er | Metformin Hcl | 60 | 14 |
| Metronidazole | Metronidazole | 60 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 60 | suppressed |
| Atenolol | Atenolol | 59 | suppressed |
| Azithromycin | Azithromycin | 56 | 33 |
| Valsartan | Valsartan | 55 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 54 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 54 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 54 | 15 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 53 | suppressed |
| Rivastigmine | Rivastigmine | 53 | suppressed |
| Cimetidine | Cimetidine | 52 | 12 |
| Rivastigmine | Rivastigmine Tartrate | 52 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 50 | 16 |
| Propranolol Hcl | Propranolol Hcl | 50 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 49 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 49 | 22 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 49 | 43 |
| Xultophy 100-3.6 | Insulin Degludec/Liraglutide | 49 | suppressed |
| Calcitriol | Calcitriol | 48 | 11 |
| Fenofibrate | Fenofibrate | 48 | suppressed |
| Lidocaine | Lidocaine | 48 | 15 |
| Glimepiride | Glimepiride | 46 | 13 |
| Diazepam | Diazepam | 45 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 45 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 44 | 14 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 44 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 44 | 17 |
| Propafenone Hcl | Propafenone Hcl | 44 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 25 |
| Breo Ellipta | Fluticasone/Vilanterol | 42 | 12 |
| Galantamine Hbr | Galantamine Hbr | 42 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 42 | 14 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 42 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 41 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 41 | 17 |
| Levofloxacin | Levofloxacin | 41 | 23 |
| Methocarbamol | Methocarbamol | 41 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 40 | suppressed |
| Niacin Er | Niacin | 40 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 39 | 24 |
| Lovastatin | Lovastatin | 39 | suppressed |
| Metolazone | Metolazone | 39 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 38 | 13 |
| Irbesartan | Irbesartan | 38 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 38 | 38 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 38 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 38 | suppressed |
| Dexamethasone | Dexamethasone | 37 | 35 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | 11 |
| Vancomycin Hcl | Vancomycin Hcl | 37 | 12 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 36 | suppressed |
| Modafinil | Modafinil | 36 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 36 | suppressed |
| Carbamazepine | Carbamazepine | 35 | suppressed |
| Klayesta | Nystatin | 35 | 15 |
| Nuplazid | Pimavanserin Tartrate | 35 | suppressed |
| Trandolapril | Trandolapril | 35 | suppressed |
| Methadone Hcl | Methadone Hcl | 34 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 34 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 33 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 33 | 13 |
| Bupropion Hcl | Bupropion Hcl | 32 | suppressed |
| Clonidine | Clonidine | 32 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 32 | 13 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 32 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 31 | 18 |
| Diltiazem 24hr Er | Diltiazem Hcl | 31 | suppressed |
| Fentanyl | Fentanyl | 31 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 31 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 30 | suppressed |
| Lansoprazole | Lansoprazole | 30 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Lubiprostone | Lubiprostone | 30 | suppressed |
| Mupirocin | Mupirocin | 30 | 16 |
| Verapamil Er | Verapamil Hcl | 30 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 29 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 29 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 29 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 28 | suppressed |
| Ibuprofen | Ibuprofen | 28 | 14 |
| Ketoconazole | Ketoconazole | 28 | 17 |
| Nitroglycerin | Nitroglycerin | 28 | 23 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 27 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 19 |
| Haloperidol | Haloperidol | 27 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 27 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 27 | 15 |
| Sotalol | Sotalol Hcl | 27 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 27 | suppressed |
| Anastrozole | Anastrozole | 25 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 25 | suppressed |
| Formoterol Fumarate | Formoterol Fumarate | 25 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 25 | suppressed |
| Roflumilast | Roflumilast | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 16 |
| Arformoterol Tartrate | Arformoterol Tartrate | 24 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 24 | suppressed |
| Xifaxan | Rifaximin | 24 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 23 | 23 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 23 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 23 | 11 |
| Humulin R | Insulin Regular, Human | 23 | suppressed |
| Hydrocortisone | Hydrocortisone | 23 | 16 |
| Loperamide | Loperamide Hcl | 23 | 15 |
| Naproxen | Naproxen | 23 | suppressed |
| Amantadine | Amantadine Hcl | 22 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 22 | suppressed |
| Lacosamide | Lacosamide | 22 | suppressed |
| Ssd | Silver Sulfadiazine | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 21 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 21 | 13 |
| Nadolol | Nadolol | 21 | suppressed |
| Procrit | Epoetin Alfa | 21 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Armour Thyroid | Thyroid,pork | 20 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 20 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Klor-Con 10 | Potassium Chloride | 20 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 20 | 17 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 20 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 20 | suppressed |
| Restasis | Cyclosporine | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Creon | Lipase/Protease/Amylase | 19 | suppressed |
| Cyclosporine | Cyclosporine | 19 | suppressed |
| Diclofenac Epolamine | Diclofenac Epolamine | 19 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 19 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 18 | 13 |
| Sodium Bicarbonate | Sodium Bicarbonate | 18 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Briviact | Brivaracetam | 17 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 17 | suppressed |
| Paliperidone Er | Paliperidone | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 16 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Repatha Syringe | Evolocumab | 16 | suppressed |
| Amoxapine | Amoxapine | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Carbamazepine Er | Carbamazepine | 15 | suppressed |
| Enulose | Lactulose | 15 | suppressed |
| Erythromycin | Erythromycin Base | 15 | 12 |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Linezolid | Linezolid | 15 | suppressed |
| Mirabegron Er | Mirabegron | 15 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 15 | 13 |
| Phenytoin | Phenytoin | 15 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 15 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 14 | 14 |
| Betaseron | Interferon Beta-1b | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Ingrezza | Valbenazine Tosylate | 14 | suppressed |
| Lamotrigine Er | Lamotrigine | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 14 | suppressed |
| Rybelsus | Semaglutide | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Admelog | Insulin Lispro | 13 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 13 | suppressed |
| Austedo | Deutetrabenazine | 13 | suppressed |
| Betimol | Timolol | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 13 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 13 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 13 | suppressed |
| Dronabinol | Dronabinol | 13 | suppressed |
| Fluvoxamine Maleate Er | Fluvoxamine Maleate | 13 | suppressed |
| Glyburide | Glyburide | 13 | suppressed |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Loxapine | Loxapine Succinate | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Rexulti | Brexpiprazole | 13 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 13 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 13 | suppressed |
| Vascepa | Icosapent Ethyl | 13 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Perphenazine | Perphenazine | 12 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Novolin R | Insulin Regular, Human | 11 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Propafenone Hcl Er | Propafenone Hcl | 11 | suppressed |
| Ramelteon | Ramelteon | 11 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $337.34 · 18 records | PFIZER INC. | AREXVY, Arikayce, Cologuard Collection Kit, Dexcom G6 Transmitter, ELIQUIS, EVENITY, FANAPT, NURTEC ODT, Ozempic, REXULTI, SHINGRIX, ZAVZPRET, Zunveyl | 9 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Arexvy play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error